4//SEC Filing
CORIXA CORP 4
Accession 0001209191-05-037072
CIK 0001042561operating
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 1:37 PM ET
Size
28.3 KB
Accession
0001209191-05-037072
Insider Transaction Report
Form 4
CORIXA CORPCRXA
FANNING DAVID
Sr. Vice President, COO
Transactions
- Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−10,938→ 0 totalExercise: $6.41From: 2005-07-12Exp: 2013-01-03→ Common Stock (10,938 underlying) - Exercise/Conversion
Common Stock
2005-07-12$3.95/sh+150,000$592,500→ 181,026 total - Disposition to Issuer
Common Stock
2005-07-12$4.40/sh−150,000$660,000→ 31,026 total - Disposition to Issuer
Common Stock
2005-07-12$4.40/sh−31,026$136,514→ 0 total - Exercise/Conversion
Incentive Stock Option
2005-07-12−150,000→ 0 totalExercise: $3.95From: 2005-07-12Exp: 2014-12-15→ Common Stock (150,000 underlying) - Disposition to Issuer
Incentive Stock Option
2005-07-12−21,094→ 0 totalExercise: $6.04From: 2005-07-12Exp: 2013-12-31→ Common Stock (21,094 underlying) - Disposition to Issuer
Incentive Stock Option
2005-07-12−4,062→ 0 totalExercise: $6.41From: 2005-07-12Exp: 2013-01-03→ Common Stock (4,062 underlying) - Disposition to Issuer
Incentive Stock Option
2005-07-12−46,793→ 0 totalExercise: $10.40From: 2005-07-12Exp: 2011-10-01→ Common Stock (46,793 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−253,207→ 0 totalExercise: $10.40From: 2005-07-12Exp: 2011-10-01→ Common Stock (253,207 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−50,000→ 0 totalExercise: $6.70From: 2005-07-12Exp: 2012-10-04→ Common Stock (50,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−75,000→ 0 totalExercise: $5.70From: 2005-07-12Exp: 2014-12-15→ Common Stock (75,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−19,406→ 0 totalExercise: $6.04From: 2005-07-12Exp: 2013-12-31→ Common Stock (19,406 underlying)
Footnotes (2)
- [F1]Pursuant to the Merger Agreement with GSK, these options were cancelled at the time the merger. Net cash consideration was received.
- [F2]Pursuant to the Merger Agreement with GSK, the underlying option was cancelled cancelled at the time of the Merger. No cash consideration was received for the cancellation.
Documents
Issuer
CORIXA CORP
CIK 0001042561
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001042561
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 1:37 PM ET
- Size
- 28.3 KB